SLEEP AND POLYENDOCRINE METABOLIC OVARIAN SYNDROME: ANALYZING THE BIDIRECTIONAL RELATIONSHIP. A LITERATURE REVIEW
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6248Keywords:
Polyendocrine Metabolic Ovarian Syndrome, PMOS, Polycystic Ovary Syndrome, PCOS, Circadian Rhythm Disruption, Sleep, Sleep Architecture, MelatoninAbstract
Polyendocrine metabolic ovarian syndrome (PMOS) represents a prevalent endocrine disorder whose pathogenesis is driven by a complex network of underlying mechanisms. Emerging evidence highlights disrupted sleep architecture and circadian dysregulation as significant contributors to PMOS progression, suggesting that targeting these pathways could optimize clinical management.
Aim: The aim of this article is to review recent data regarding the impact of sleep alterations and biological rhythm disturbances on PMOS, while evaluating therapeutic strategies helping to restore sleep health.
Material and methods: A comprehensive literature review was conducted utilizing the PubMed and Google Scholar databases to identify peer-reviewed articles published between 2001 and 2026.
Results: Sleep abnormalities correlate strongly with the clinical severity of PMOS, though the precise physiological pathways mediating this interaction remain to be fully discovered. Circadian desynchronization and blunted melatonin pathways significantly exacerbate metabolic dysfunction and disrupt reproductive hormone regulation. Concurrently, comorbid obstructive sleep apnea (OSA) accelerates cardiovascular risk, whereas psychological distress, such as depression, impairs sleep quality and diminishes patient compliance with essential lifestyle modifications.
Conclusions: Further investigation is required to clarify the exact impact of sleep deprivation on PMOS pathophysiology. Behavioral therapies, chronobiological tools and continuous clinical support offer encouraging strategies and seem to significantly improve patients quality of life. However, future clinical trials are undoubtedly urgently needed to establish optimal management protocols for this population.
References
Alvaro, P.K., Roberts, R.M., Harris, J.K. (2013). A systematic review assessing bidirectionality between sleep disturbances, anxiety, and depression. Sleep. 2013;36(7):1059–1068.
Alzueta, E., de Zambotti, M., Javitz, H., Dulai, T., Albinni, B., Simon, K.C., Sattari, N., Zhang, J., Shuster, A., Mednick, S.C., Baker, F.C. (2022). Tracking Sleep, Temperature, Heart Rate, and Daily Symptoms Across the Menstrual Cycle with the Oura Ring in Healthy Women. Int J Womens Health. 2022 Apr 8:14:491-503.
Barrea, L., Verde, L., Vetrani, C., Docimo, A., de Alteriis, G., Savastano, S., Colao, A., Muscogiuri, G. (2023). Evening chronotype is associated with hormonal and metabolic disorders in polycystic ovary syndrome. J Pineal Res 2023;74(02):e12844.
Bennett, C.J., Mansfield, D.R., Mo, L., Joham, A.E., Cain, S.W., Blumfield, M.L., Hodge, A.M., Moran, L.J. (2021). Sleep disturbances may influence lifestyle behaviours in women with self-reported polycystic ovary syndrome. British Journal of Nutrition, 127(9), 1395–1403.
Bose, M., Oliván, B., Laferrère, B. (2009). Stress and obesity: the role of the hypothalamic-pituitary-adrenal axis in metabolic disease. Curr Opin Endocrinol Diabetes Obes (2009) 16(5):340–6.
Cappuccio, F.P., Miller, M.A., Lockley, S.W. (2010). Sleep, Health and Society: From Aetiology to Public Health. Oxford, 2010; online edn, Oxford Academic, 1 Jan. 2011.
Cappuccio, F.P., Miller, M.A. (2017). Sleep and cardio-metabolic disease. Curr Cardiol Rep 2017;19(11):110.
Cowan, S., Lim, S., Alycia, C., Pirotta, S., Thomson, R., Gibson-Helm, M., Blackmore, R., Naderpoor, N., Bennett, C., Ee, C., Rao, V., Mousa, A., Alesi, S., Moran, L. (2023). Lifestyle management in polycystic ovary syndrome – beyond diet and physical activity. BMC Endocr Disord. 2023 Jan 16;23:14.
Decrinis, C., Hofmann, K., Bitterlich, N., Singer, A., Tropschuh, K., Lozza-Fiaco, S., Estermann, J., Bachmann, A., Stute, P. (2025). Sleep disorders and psychological comorbidities in women with polycystic ovary syndrome – a cross-sectional study. Arch Gynecol Obstet 312, 573–582 (2025).
de Sousa, G., Schlüter, B., Buschatz, D., Menke, T., Trowitzsch, E., Andler, W., Reinehr, T. (2010). A comparison of polysomnographic variables between obese adolescents with polycystic ovarian syndrome and healthy, normal-weight and obese adolescents. Sleep Breath 2010;14(01):33–38.
Ehrmann, D.A. (2011). Metabolic dysfunction in PCOS: relationship to obstructive sleep apnea. Steroids. 2012;77(4):290–294.
Eisenberg, E., Legro, R.S., Diamond, M.P., Huang, H., O’Brien, L.M., Smith, Y.R., Coutifaris, C., Hansen, K.R., Santoro, N., Zhang, H. (2021). Sleep Habits of Women With Infertility. J Clin Endocrinol Metab. 2021 Jun 28;106(11):e4414–e4426.
Gautam, R., Maan, P., Jyoti, A., Kumar, A., Malhotra, N., Arora, T. (2025). The Role of Lifestyle Interventions in PCOS Management: A Systematic Review. Nutrients. 2025 Jan 16;17(2):310.
Hawkins, S.M., Matzuk, M.M. (2008). The menstrual cycle: basic biology. Ann N Y Acad Sci. 2008;1135(1):10–18.
Heydari, T., Ramdass, P.V.A.K. (2025). Circadian rhythm disruption and polycystic ovary syndrome: a systematic review and meta-analysis. AJOG Glob Rep. 2025 Mar 20;5(2):100479.
Hood, S., Amir, S. (2018). Biological clocks and rhythms of anger and aggression. Front Behav Neurosci 2018;12:4.
Jafar, N.K.A., Bennett, C.J., Moran, L.J., Mansfield, D.R. (2023). Beyond Counting Sheep: Exploring the Link between Polycystic Ovary Syndrome and Sleep Health. Semin Reprod Med. 2023 Mar;41(1-02):45-58.
Jafar, N.K.A., Fan, M., Moran, L.J., Mansfield, D.R., Bennett, C.J. (2025). Sex Hormones, Sex Hormone-Binding Globulin and Sleep Problems in Females With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Clin Endocrinol (Oxf). 2025 Jun;102(6):708-720.
Joshi, A. (2024). PCOS stratification for precision diagnostics and treatment. Front Cell Dev Biol. 2024 Feb 8;12:1358755.
Li, J., Huang, Y., Xu, S., Wang, Y. (2024). Sleep disturbances and female infertility: a systematic review. BMC Womens Health. 2024 Dec 20;24:643.
Messinis, I.E., Messini, C.I., Dafopoulos, K. (2014). Novel aspects of the endocrinology of the menstrual cycle. Reprod Biomed Online. 2014;28(6):714–722.
Mo, L., Mansfield, D.R., Joham, A., Cain, S.W., Bennett, C., Blumfield, M., Teede, H., Moran, L.J. (2018). Sleep disturbances in women with and without polycystic ovary syndrome in an Australian National Cohort. Clin Endocrinol (Oxf). 2019 Apr;90(4):570-578.
Oberg, E., Blomberg, L., Åkerstedt, T., Hirschberg, A.L. (2023). Different sleep pattern in over-weight/obese women with polycystic ovary syndrome. Front Endocrinol 2023:141068045.
Pacchiarotti, A. (Alessandro), Carlomagno, G., Antonini, G., Pacchiarotti, A. (Arianna) (2015). Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome. Gynecol Endocrinol. 2016;32(1):69–73.
Pan, X., Taylor, M.J., Cohen, E., Hanna, N., Mota, S. (2020). Circadian Clock, Time-Restricted Feeding and Reproduction. Int J Mol Sci 2020, 21(3):831.
Pirotta, S., Joham, A.J., Moran, L.J., Skouteris, H., Lim, S.S. (2021). Implementation of evidence-based PCOS lifestyle management guidelines: Perceived barriers and facilitators by consumers using the Theoretical Domains Framework and COM-B Model. Patient Educ Couns. 2021;104(8):2080–2088.
Sateia, M.J. (2014). International classification of sleep disorders-third edition: highlights and modifications. Chest 2014;146(05): 1387–1394.
Sciarra, F., Franceschini, E., Campolo, F., Gianfrilli, D., Pallotti, F., Paoli, D., Isidori, A.M., Venneri, M.A. (2020). Disruption of Circadian Rhythms: A Crucial Factor in the Etiology of Infertility. Int J Mol Sci 2020, 21(11):3943.
Sellix, M.T. (2013). Clocks underneath: the role of peripheral clocks in the timing of female reproductive physiology. Front Endocrinol (Lausanne). 2013;4:91.
Siddiqui, S., Mateen, S., Ahmad R., Moin S. (2022). A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J Assist Reprod Genet. 2022 Nov;39(11):2439-2473.
Simon, S., Rahat, H., Carreau, A-M., Garcia-Reyes, Y., Halbower, A., Pyle, L., Nadeau, K.J., Cree-Green, M. (2020). Poor sleep is related to metabolic syndrome severity in adolescents with PCOS and obesity. J Clin Endocrinol Metab 2020;105(04):e1827–e1834.
Stańczak, N.A., Grywalska, E., Dudzińska, E. (2024). The latest reports and treatment methods on polycystic ovary syndrome. Ann Med. 2024 Dec;56(1):2357737.
Teede, H.J., Tay, C.T., Laven, J.J.E., Dokras, A., Moran, L.J., Piltonen, T.T., Costello, M.F., Boivin, J., Redman, L.M., Boyle, J.A., Norman, R.J., Mousa, A., Joham, A.E. (2023). Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023 Aug 15;108(10):2447–2469.
Teede, H.J., Khomami, M.B., Morman, R., Laven, J.S.E., Joham, A.E., Costello, M.F., Patil, M., Rees, D.A., Berry, L., Cree, M.G., Zhao, H., Norman, R.J., Dokras, A., Piltonen, T., Global Name Change Consortium (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026 Jun 6;407(10545):2329-2339.
Teo, P., Henry, B.A., Moran, L.J., Cowan, S., Bennett, C. (2022). The role of sleep in PCOS: what we know and what to consider in the future. Expert Rev Endocrinol Metab 2022;17(04):305–318.
Vgontzas, A.N., Legro, R.S., Bixler, E.O., Grayev, A., Kales, A., Chrousos, G.P. (2001). Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab. 2001;86(2):517–520. doi: 10.1210/jcem.86.2.7185.
Walker, W.H. II, Walton, J.C., DeVries, A.C., Nelson, R.J. (2020). Circadian rhythm disruption and mental health. Transl Psychiatry 2020; 10(01):28.
Wang, C., Huang, T., Song, W., Zhu, J., Liu, Y., Chen, X., Sun, X., Wu, Q., Chen, H., Liao, H., Lin, J., Ou, X., Zou, Z., Wang, Z., Zheng, Z., Wu, K., Chen, R. (2022).
A meta-analysis of the relationship between polycystic ovary syndrome and sleep disturbances risk. Front. Physiol., 29 September 2022 Sec. Reproduction. Volume 13 - 2022.
Wittmann, M., Dinich, J., Merrow, M., Roenneberg, T. (2006). Social jetlag: misalignment of biological and social time. Chronobiol Int 2006; 23(1-2):497–509.
Yang, Y., Deng, H., Li, T., Xia, M., Liu, C., Bu, X.-Q., Li, H., Fu, L.-J., Zhong, Z.-H. (2021). The mental health of Chinese women with polycystic ovary syndrome is related to sleep disorders, not disease status. J Affect Disord (2021) 282:51–7.
Zhang, J., Ye, J., Tao, X., Lu, W., Chen, X., Liu, C. (2022). Sleep disturbances, sleep quality, and cardiovascular risk factors in women with polycystic ovary syndrome: Systematic review and meta-analysis. Front. Endocrinol. 13:971604.
Zisapel, N. (2018). New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br J Pharmacol. 2018;175(16):3190–9.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Agnieszka Cichocka, Agata Agnieszka Cieślik, Mateusz Gąbka, Jadwiga Pelc, Agata Cieślik, Magdalena Cieślik-Porębska
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
